The ethics of expanding access to cheaper, less effective treatments

The Lancet (10047):S0140-6736(15)01025-9 (2016)
  Copy   BIBTEX

Abstract

This article examines a fundamental question of justice in global health. Is it ethically preferable to provide a larger number of people with cheaper treatments that are less effective (or more toxic), or to restrict treatments to a smaller group to provide a more expensive but more effective or less toxic alternative? We argue that choosing to provide less effective or more toxic interventions to a larger number of people is favored by the principles of utility, equality, and priority for those worst-off. Advocates are mistaken to demand that medical care provided in low-income and middle-income countries should be the same as in high-income countries.

Author's Profile

Govind Persad
University of Denver

Analytics

Added to PP
2016-08-18

Downloads
545 (#27,913)

6 months
49 (#73,837)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?